Adjuvant ganglioside GM2-KLH/QS-21 vaccination versus observation after resection of primary tumor > 1.5 mm in patients with stage II melanoma: results of the EORTC 18961 randomized phase III trial (Q34982581)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Adjuvant ganglioside GM2-KLH/QS-21 vaccination versus observation after resection of primary tumor > 1.5 mm in patients with stage II melanoma: results of the EORTC 18961 randomized phase III trial |
scientific article |
Statements
1 reference
Adjuvant ganglioside GM2-KLH/QS-21 vaccination versus observation after resection of primary tumor > 1.5 mm in patients with stage II melanoma: results of the EORTC 18961 randomized phase III trial (English)
1 reference
Alexander M M Eggermont
1 reference
Paolo A Ascierto
1 reference
Piotr Rutkowski
1 reference
Stefan Suciu
1 reference
Jeremy Marsden
1 reference
Mario Santinami
1 reference
Philippa Corrie
1 reference
Steinar Aamdal
1 reference
Poulam M Patel
1 reference
Wim H Kruit
1 reference
Lars Bastholt
1 reference
Lorenzo Borgognoni
1 reference
Maria Grazia Bernengo
1 reference
Neville Davidson
1 reference
Larissa Polders
1 reference
Michel Praet
1 reference
Alan Spatz
1 reference
9 September 2013
1 reference
1 reference
31
1 reference
30
1 reference
3831-3837
1 reference
Identifiers
1 reference
1 reference